Cargando…

Editorial: Prognostic factors in non-small cell lung cancer

Detalles Bibliográficos
Autores principales:	Rahouma, Mohamed, Baudo, Massimo, Zhang, Jun, Mutti, Luciano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043477/ https://www.ncbi.nlm.nih.gov/pubmed/36998444 http://dx.doi.org/10.3389/fonc.2023.1174625

Ejemplares similares

Editorial: Editor’s challenge: Mohamed Rahouma - how can we optimize the management and treatment of cardiac tumors and cardiac complications of cancer?
por: Rahouma, Mohamed, et al.
Publicado: (2023)

Anti-PDL1 effect in squamous non-small cell lung cancer
por: Rahouma, Mohamed, et al.
Publicado: (2020)

Editorial: Factors that impact the survival of non-small cell lung cancer
por: Hegi-Johnson, Fiona, et al.
Publicado: (2023)

Editorial: Imaging in non-small cell lung cancer
por: Liu, Yiyan
Publicado: (2023)

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer
por: Shen, Qinglin, et al.
Publicado: (2023)

Commentary: Left ventricular assist device infections and epidemiologic literature—still more work to be done
por: Mynard, J. Nathan, et al.
Publicado: (2021)

Editorial: Treatment for Non-Small Cell Lung Cancer in Distinct Patient Populations
por: Uchino, Junji, et al.
Publicado: (2022)

Development of a Survival Prognostic Model for Non-small Cell Lung Cancer
por: Zhang, Yue-Hua, et al.
Publicado: (2020)

The function and clinical implication of circular RNAs in lung cancer
por: Ren, Wenjun, et al.
Publicado: (2022)

CDK7 is a prognostic biomarker for non-small cell lung cancer
por: Kuempers, Christiane, et al.
Publicado: (2022)

Prognostic Implication of the Expression Level of PECAM-1 in Non-small Cell Lung Cancer
por: Cao, Shuhui, et al.
Publicado: (2021)

Editorial: Editor's challenge: Dr. Luciano Mutti - what is the true impact of ICIs on survival in the treatment of thoracic malignancies?
por: Mutti, Luciano, et al.
Publicado: (2023)

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients
por: Pankova, Olga V., et al.
Publicado: (2021)

Comprehensive Analysis of Immune Implication and Prognostic Value of IFI44L in Non-Small Cell Lung Cancer
por: Zeng, Yong, et al.
Publicado: (2022)

Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer
por: Boscolo, Alice, et al.
Publicado: (2020)

Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer
por: Su, Dan, et al.
Publicado: (2021)

Geographic variation in malignant cardiac tumors and their outcomes: SEER database analysis
por: Rahouma, Mohamed, et al.
Publicado: (2023)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

The Role of Transcriptional Factor Brachyury on Cell Cycle Regulation in Non-small Cell Lung Cancer
por: Xu, Jingyi, et al.
Publicado: (2020)

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer
por: Puri, Sonam, et al.
Publicado: (2020)

Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer
por: Zeng, Yangyang, et al.
Publicado: (2021)

Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer
por: Jeremić, Branislav, et al.
Publicado: (2018)

Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-small Cell Lung Cancer
por: Khandelwal, Akanksha, et al.
Publicado: (2021)

Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade
por: Nardone, Valerio, et al.
Publicado: (2021)

Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
por: Melosky, Barbara
Publicado: (2017)

A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer
por: He, Ru, et al.
Publicado: (2019)

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer
por: Daniello, Lea, et al.
Publicado: (2021)

WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer
por: Li, Zheng, et al.
Publicado: (2022)

Predictive power of deep-learning segmentation based prognostication model in non-small cell lung cancer
por: Gainey, Jordan C., et al.
Publicado: (2023)

Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients
por: Li, Hang, et al.
Publicado: (2021)

The Application of Combined Immune Checkpoint Inhibitor Modalities in Previously Treated Non-Small Cell Lung Cancer Patients and the Associations Thereof With the Lung Immune Prognostic Index
por: Zhang, Ting, et al.
Publicado: (2021)

Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer
por: Wang, Wenxian, et al.
Publicado: (2020)

Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma
por: Chen, Xi, et al.
Publicado: (2022)

Current treatments for non-small cell lung cancer
por: Guo, Qianqian, et al.
Publicado: (2022)

Downregulation of CISD2 Has Prognostic Value in Non-Small Cell Lung Cancer and Inhibits the Tumorigenesis by Inducing Mitochondrial Dysfunction
por: Shao, Fangchun, et al.
Publicado: (2021)

A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population
por: Wang, Lijie, et al.
Publicado: (2022)

The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
por: Chen, Haiqing, et al.
Publicado: (2021)

Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer
por: Gemelli, Maria, et al.
Publicado: (2022)

Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity
por: Qi, Jing, et al.
Publicado: (2022)

Exploratory Study of a CT Radiomics Model for the Classification of Small Cell Lung Cancer and Non-small-Cell Lung Cancer
por: Liu, Shihe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qbeijlbtfl0qaimohto0vgkg44